FDA’s ‘Radical’ Abortion Pill Stance Fails, 5th Circ. Told

By Hannah Albarazi (May 9, 2023, 10:15 PM EDT) — Anti-abortion groups challenging the U.S. Food and Drug Administration’s approval of mifepristone in 2000 slammed the agency’s allegedly “decades-long pattern of delay and obfuscation” and urged the Fifth Circuit to uphold a Texas ruling that would have blocked access to the common abortifacient last month had the U.S. Supreme Court not intervened….

Read more

Explore the site

More from the blog

Latest News